Teleflex (NYSE:TFX – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 13.950-14.350 for the period, compared to the consensus estimate of 15.230. The company issued revenue guidance of $3.0 billion-$3.1 billion, compared to the consensus revenue estimate of $3.2 billion.
Wall Street Analysts Forecast Growth
TFX has been the subject of several recent research reports. Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday. Piper Sandler restated a “neutral” rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Friday. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Truist Financial reduced their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Nine equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $196.83.
Get Our Latest Analysis on TFX
Teleflex Stock Down 4.7 %
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. On average, equities analysts expect that Teleflex will post 13.98 EPS for the current year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s payout ratio is 27.04%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
- Five stocks we like better than Teleflex
- Upcoming IPO Stock Lockup Period, Explained
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.